INOTUZUMAB OZOGAMICIN IN RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKAEMIA: A REAL-WORLD RETROSPECTIVE STUDY IN THE UK

EHA Library, David Marks, 325125

AGEING MIMICS LEUKEMIC ADAPTATION OF BONE MARROW STROMAL CELLS AND PROMOTES ACUTE MYELOID LEUKEMIA INITIATION

EHA Library, Xiying Ren, 325131

SELECTIVE REQUIREMENT OF MYB FOR ONCOGENIC HYPERACTIVATION OF A TRANSLOCATED ENHANCER IN ACUTE MYELOID LEUKEMIA

EHA Library, Leonie Smeenk, 325132

MENIN INHIBITION DECREASES BCL-2 AND SYNERGIZES WITH VENETOCLAX IN NPM1/FLT3-MUTATED AML

EHA Library, Bing Carter, 325133

NUP98/NSD1-POSITIVE AML IS ADDICTED TO A FUNCTIONAL MENIN-MLL INTERACTION

EHA Library, Milad Rasouli, 325136

CIRCULATING EXTRACELLULAR VESICLES FROM ACUTE MYELOID LEUKEMIA PATIENTS REVEAL SPHINGOLIPID DEPLETION AND REDOX METABOLIC FUNCTION

EHA Library, Dorian Forte, 325138

FILT3R: AN NGS-BASED ALGORITHM FOR ROBUST DETECTION AND QUANTIFICATION OF FLT3-ITD IN CLINICAL PRACTICE

EHA Library, Augustin Boudry, 325139

FREQUENCY AND STIMULATION OF NPM1-SPECIFIC IMMUNE RESPONSES BY ANTI-PD1 ANTI-BODIES IN NPM1-MUTATED AML

EHA Library, Jochen Greiner, 325140

TARGETING THE IRE1Α-XBP1 PATHWAY INDUCES APOPTOSIS IN FLT3-ITD+ AML AND ENHANCES THE EFFECT OF TKI INDUCED FLT3-ITD INHIBITION

EHA Library, Timo Jaquet, 325141

SWATH-MS PROTEOMIC ANALYSIS IDENTIFIES C/EBPΒ SUPPRESSION BY RUNX1-ETO AS A POTENTIAL MEDIATOR OF BLOCK IN DIFFERENTIATION

EHA Library, Aleksandra Azevedo, 325142

RECURRENT DELETIONS IN CLONAL HEMATOPOIESIS ARE DRIVEN BY MICROHOMOLOGY-MEDIATED END JOINING

EHA Library, Tzah Feldman, 325145

TARGETING THE RUNX1-RUNX1T1 FUSION GENE USING CRISPR-CAS9 TECHNOLOGY EFFECTIVELY INHIBITS PROLIFERATION AND DECREASES TUMOR VOLUME IN VITRO AND IN VIVO

EHA Library, Signe Neldeborg, 325146

NK-CELLS EXHAUSTION WHICH DUE TO NKG2A OVER-EXPRESSION IS ASSOCIATE WITH RELAPSED IN ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Xue-Fei Liu, 325149

DIFFERENTIATION OF ACUTE MYELOID LEUKEMIA SUBTYPES BY SERUM-BASED SPECTROSCOPY COUPLING WITH NON-TARGETED METABOLIC FINGERPRINTS

EHA Library, Yang Chen, 325151

MEGAKARYOCYTIC TRANSCRIPTION FACTOR ARID3A SUPPRESSES GATA1S-INDUCED MALIGNANT TRANSFORMATION

EHA Library, Oriol Alejo-Valle, 325152

SIGNALLING INTERACTIONS OF MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS AT TIME OF DIAGNOSIS PREDICT SURVIVAL IN ACUTE MYELOID LEUKAEMIA

EHA Library, Dimitrios Kleftogiannis, 325153

THE NOVEL ORAL BET-CBP/P300 DUAL INHIBITOR NEO2734 IS HIGHLY EFFECTIVE IN ERADICATING ACUTE MYELOID LEUKEMIA BLASTS AND STEM/PROGENITOR CELLS

EHA Library, Noortje van Gils, 325154

POLYFUNCTIONALITY DETERMINED BY SINGLE-CELL PROTEOMICS OF BONE MARROW-DERIVED CD4 T-CELLS FROM PATIENTS WITH ACUTE MYELOID LEUKEMIA PREDICTS PATIENTS RESPONDING TO ANTI-PD-1-BASED THERAPY

EHA Library, Hussein Abbas, 325155

RAPID GENOMIC PROFILING IN ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CYTOGENETIC ABERRATIONS

EHA Library, Anna Dolnik, 325156

ENHANCED EFFICACY OF THE DCP-001 RELAPSE VACCINE WHEN COMBINED WITH VENETOCLAX AND 5-AZACITIDINE IN A HUMANISED IMMUNOCOMPETENT MOUSE MODEL OF AML

EHA Library, Satwinder Kaur Singh, 325157

TARGETING DOWN SYNDROME-ASSOCIATED LEUKEMIA AT ITS CORE: LSD1 INHIBITION IN COMBINATION WITH DISRUPTION OF JAK-STAT SIGNALING

EHA Library, Juliane Grimm, 325158

TREATMENT IS SHAPING CLONAL EVOLUTION AND RESISTANCE PATTERNS IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K

EHA Library, Ton Falqués Costa, 325160

COMPUTER AIDED DESIGN (CAD) FLOW IN ASSESSMENT OF AML MRD FLOW -ALFA FRENCH FLOW AML MRD INTERGROUP

EHA Library, Florent Dumezy, 325161

THE IMPACT OF MUTATIONAL LOAD (VAF) DETECTED IN THE TP53, EZH2, U2AF1, WT1, FLT3 AND SF3B1 GENES WAS IDENTIFIED AS AN INDEPENDENT PROGNOSTIC MARKER FOR OS OR RFS IN A COHORT OF 497 CASES WITH AML

EHA Library, Noemí Álvarez Sánchez-Redondo, 325162

COMBINATORIAL INHIBITION OF TIGIT AND CD39 INCREASE T-CELL MEDIATED KILLING IN AML

EHA Library, Franziska Brauneck, 325164

NEW CUSTOM ALGORITHM FOR COPY NUMBER DETECTION IN MYELOID MALIGNANCIES USING A TARGETED NGS PANEL

EHA Library, Beñat Ariceta, 325165

THE MOLECULAR BASIS AND CLINICAL OUTCOMES OF CALM-MLLT10 FUSION POSITIVE ACUTE LEUKEMIA

EHA Library, Tong Wang, 325168

PRL-PRLR AXIS IMPLICATION IN CHEMORESISTANCE AND PROLIFERATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Laia Cuesta-Casanovas, 325169

MAIT CELLS NUMBERS AND FREQUENCIES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AT DIAGNOSIS: ASSOCIATION WITH CYTOGENETIC PROFILE AND GENE MUTATIONS.

EHA Library, Thibault Comont, 325170

CHECKPOINT KINASE 1 IS OVEREXPRESSED, BY POST-TRANSCRIPTIONAL REGULATION, IN IMMATURE AND MONOBLASTIC / MONOCYTIC ACUTE MYELOID LEUKEMIA

EHA Library, Leonor M. Sarmento, 325172

METABOLIC PECULIARITY OF PML/RARA EXPRESSING CELLS AND ARSENIC TRIOXIDE RESISTANCE

EHA Library, Nelida I. Noguera, 325174

ZINC IN THE MODULATION OF THE DNA DAMAGE RESPONSE – PREVENTIVE, GENOTOXIC AND CYTOTOXIC ROLES IN ACUTE MYELOID LEUKEMIA

EHA Library, Ana Bela Sarmento-Ribeiro, 325175

LINKING CDK6 TO THE EPIGENOME

EHA Library, Karoline Kollmann, 325176

MELFLUFEN DEMONSTRATES HIGH EFFICACY IN CYTARABINE AND VENETOCLAX RESISTANT AML MODELS

EHA Library, Ana Slipicevic, 325178

ASSOCIATION OF ATG10 FUNCTIONAL GENETIC VARIANTS IN ACUTE MYELOID LEUKEMIA

EHA Library, Anabela Areias, 325179

QUIZARTINIB WITH DECITABINE AND VENETOCLAX (TRIPLET) IS HIGHLY ACTIVE IN PATIENTS WITH FLT3-ITD MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Musa Yilmaz, 325184

VALIDATION AND CLINICAL APPLICATION OF AN UNSUPERVISED ANALYSIS APPROACH TO MEASURABLE RESIDUAL DISEASE TESTING IN ACUTE MYELOID LEUKEMIA

EHA Library, Nicholas McCarthy, 325186

COMPARATIVE BIOAVAILABILITY OF A NOVEL ORAL FORMULATION OF ARSENIC TRIOXIDE IN PATIENTS UNDERGOING CONSOLIDATION THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA: FINAL ANALYSIS OF THE ALLG APML5 TRIAL

EHA Library, Harry J Iland, 325187

CLINICAL IMPACT OF SENSITIVE DNMT3A, TET2, OR ASXL1 MUTATION DETECTION IN ACUTE MYELOID LEUKEMIA PATIENTS PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION

EHA Library, Madlen Jentzsch, 325189

PREVALENCE AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN THE REAL-WORLD SETTING: RESULTS FROM THE PROSPECTIVE IDH SCREENING COHORT OF THE SAL AML REGISTRY

EHA Library, Christoph Röllig, 325190

PROGNOSTIC IMPACT OF CONVENTIONAL CYTOGENETICS IN ACUTE MYELOID LEUKEMIA (AML) TREATED WITH DECITABINE AND VENETOCLAX (DEC10-VEN)

EHA Library, Sangeetha Venugopal, 325194

PRELIMINARY RESULTS OF V-FAST, A PHASE 1B MASTER TRIAL TO INVESTIGATE CPX-351 COMBINED WITH TARGETED AGENTS IN NEWLY DIAGNOSED AML

EHA Library, Vinod A. Pullarkat, 325196

PHASE 1 FIRST-IN-HUMAN STUDY OF IRREVERSIBLE FLT3 INHIBITOR FF-10101-01 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Mark Levis, 325197

HEMATOLOGIC ADVERSE EVENTS AND MANAGEMENT STRATEGIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN FIRST REMISSION RECEIVING ORAL AZACITIDINE (ORAL-AZA) IN THE PHASE 3 QUAZAR AML-001 TRIAL

EHA Library, Farhad Ravandi-Kashani, 325199

MIDOSTAURIN PLUS INTENSIVE CHEMOTHERAPY VERSUS INTENSIVE CHEMOTHERAPY IN FLT3 MUTATED ACUTE MYELOID LEUKEMIA. A RWE STUDY

EHA Library, Adolfo De La Fuente, 325201

CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA TREATED WITH GILTERITINIB WHO RECEIVED PRIOR MIDOSTAURIN OR SORAFENIB

EHA Library, Zheng Ge, 325208

CLONAL HEMATOPOIESIS IN PERIPHERAL STEM CELLS AT LEUKAPHERESIS AS PREDICTIVE FACTOR FOR THERAPY-RELATED MYELOID NEOPLASMS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION

EHA Library, Doriana Gramegna, 325209

ALICE MAINTAINS HIGH CLINICAL RESPONSE RATES SUPPORTING THE EFFICACY OF IADADEMSTAT COMBINATION WITH AZACITIDINE IN AML MANAGEMENT

EHA Library, Olga Salamero, 325210

A PHASE 1A/B DOSE ESCALATION STUDY OF THE MYC REPRESSOR APTO-253 IN PATIENTS WITH RELAPSED OR REFRACTORY AML OR HIGH-RISK MDS

EHA Library, Rafael Bejar, 325212

SYNERGISTIC EFFECT OF AZACITIDINE AND HOMOHARRINGTONINE IN ACUTE MYELOID LEUKEMIA WITH GATA2 MUTATION

EHA Library, Zheng Ge, 325213

MONITORING OF POST-TRANSPLANT MLL-PTD AS MINIMAL RESIDUAL DISEASE CAN PREDICT RELAPSE AFTER ALLOGENEIC HSCT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Mengge Gao, 325214

AZACITIDINE IN COMPARISON TO INTENSIVE CHEMOTHERAPY AND BEST SUPPORTIVE CARE IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, A DATAML REGISTRY STUDY

EHA Library, Noémie Gadaud, 325216

PROGNOSTIC IMPACT OF MINIMAL REDISUAL DISEASE ASSESSMENT IN ELDERLY PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIA. A COMPARISON BETWEEN CPX-351 AND INTENSIFIED FLUDARABINE-BASED REGIMENS

EHA Library, Fabio Guolo, 325219

ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION WAS SUPERIOR TO CONSOLIDATION CHEMOTHERAPY IN HIGH-RISK CN-AML WITH BIALLELIC CEBPA MUTATIONS BASED ON A MUTI-GENE PANEL AND NOMOGRAM MODEL

EHA Library, Li-Xin Wu, 325220

N-TERMINAL FRAGMENT OF BRAIN NATRIURETIC PEPTIDE (PBNP) IS A NOVEL INDEPENDENT PROGNOSTIC MARKER FOR SURVIVAL AND RESPONSE TO INTENSIVE CHEMOTHERAPY IN AML

EHA Library, Irene Graf, 325221

EFFICACY AND SAFETY OF ASPACYTARABINE (BST-236) AS A FIRST-LINE MONOTHERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR STANDARD CHEMOTHERAPY

EHA Library, Jessica K. Altman, 325222

TRIPLE COMBINATION OF HMA, VENETOCLAX, AND FLT3 INHIBITOR PRODUCES HIGHER FLT3 PCR CLEARANCE, FLOW MRD NEGATIVITY, AND IMPROVED MEDIAN OS COMPARED WITH DOUBLETS OF HMA WITH FLT3 INHIBITOR

EHA Library, Musa Yilmaz, 325224

PROGNOSTIC VALUE OF CRH IN ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX AND DECITABINE

EHA Library, Maria Siddiqui, 325226

ACTIVITY OF DECITABINE COMBINED WITH ALL-TRANS RETINOIC ACID IN OLIGOBLASTIC AML: RESULTS FROM A RANDOMIZED 2X2 PHASE II TRIAL

EHA Library, Christoph Rummelt, 325227

3D GENOMICS OF ACUTE MEYLOID LEUKEMIA REVEALS THE IMBALANCE BETWEEN DNA METHYLATION CANYON INTERACTIONS AND LEUKEMIC SPECIFIC ENHANCER NETWORK INTERACTIONS

EHA Library, Xiaotian Zhang, 325126

FUNCTIONAL COOPERATION OF CEBPA AND TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Elizabeth Heyes, 325127

HNRNP K OVEREXPRESSION CONTRIBUTES TO POOR PROGNOSIS AND CHEMORESISTANCE IN AML BY DEVELOPING SUPER-NUCLEOLUS

EHA Library, Pedro Aguilar-Garrido, 325128

IDH MUTATIONS DRIVE LEUKEMOGENESIS BY ONCOGENIC ACTIVATION DUE TO INSULATOR DYSFUNCTION

EHA Library, Sophie Steinhäuser, 325129

NEXT-GENERATION SEQUENCING (NGS)-BASED MEASURABLE RESIDUAL DISEASE (MRD) MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION (FLT3-ITD+ AML) TREATED WITH ADDITIONAL MIDOSTAURIN

EHA Library, Julia K. Herzig, 325130

IDENTIFICATION OF FUNCTIONAL GENETIC DEPENDENCIES AND DIRECT TRANSCRIPTIONAL TARGET GENES OF NUP98-JARID1A IN ACUTE MYELOID LEUKEMIA

EHA Library, Selina TROESTER, 325134

FUNCTIONAL ANALYSIS OF ABERRANT GENE REGULATORY PROGRAMS AND SELECTIVE DEPENDENCIES IN EVI1/MECOM-DRIVEN ACUTE MYELOID LEUKEMIA

EHA Library, Johannes Schmoellerl, 325135

MECHANISTIC STUDIES OF TENOFOVIR-DERIVED TYROSINE KINASE INHIBITORS TARGETING FLT3 IN ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 325137

GLUTATHIONE HOMEOSTASIS AND ABCC1 (MRP1) MODULATE THE RESPONSE OF ACUTE MYELOID LEUKEMIA (AML) CELLS TO BCL2 INHIBITION

EHA Library, Jessica Ebner, 325143

IRAK4 INHIBITOR CA-4948 POTENTIATES ANTITUMOR EFFECTS OF AZACITIDINE AND VENETOCLAX IN HUMAN ACUTE MYELOID LEUKEMIA

EHA Library, Andrey Ugolkov, 325144

CANONICAL WNT SIGNALING-RESPONSIVE ACUTE MYELOID LEUKEMIA CELLS ARE DEPENDENT ON BETA-CATENIN BUT NOT GAMMA-CATENIN FOR CLONAL GROWTH

EHA Library, Adam Leckenby, 325147

BASELINE SOMATIC MUTATIONS PREDICT DISEASE FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE MONOCENTRIC REPORT

EHA Library, Patrizia Chiusolo, 325148

LONGITUDINAL PATIENT-DERIVED XENOGRAFT MODELS REVEAL CONVERGENT MOLECULAR EVOLUTION IN ACUTE MYELOID LEUKAEMIA

EHA Library, Tara Dowling, 325150

MESENCHYMAL STROMAL CELLS PROTECT ACUTE MYELOID LEUKEMIA CELLS FROM VENETOCLAX-INDUCED APOPTOSIS THROUGH CONTACT-DEPENDENT MECHANISMS

EHA Library, Giulia Corradi, 325159

LONG NON-CODING RNA FAM30A AS A NOVEL REGULATOR OF LEUKEMIC STEM CELL FATE IN ACUTE MYELOID LEUKEMIA

EHA Library, Jaime Calvo Sánchez, 325163

STUDY OF THE ROLE OF SR PROTEINS IN CYTARABINE TREATMENT RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, María Luz Morales, 325166

ANALYSIS OF GERMLINE PREDISPOSITION IN PATIENTS WITH MYELOID NEOPLASMS: ASSOCIATION BETWEEN MOLECULAR ALTERATIONS AND CLINICAL HISTORY

EHA Library, Marta Santiago Balsera, 325167

PRECLINICAL DEVELOPMENT OF NOVEL COMBINED CSF1R/FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA

EHA Library, Kristine Sletta, 325171

DEEP HYPOXIA REDUCES SENSITIVITY OF ACUTE MYELOID LEUKEMIA CELL LINES TO THE PAN-AURORA INHIBITOR TOZASERTIB

EHA Library, Samantha Bruno, 325173

GENOMIC LANDSCAPE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA OLDER THAN 70 YEARS

EHA Library, Frank Rücker, 325177

IL-3 RESCUES MUTANT FLT3 AND KIT-POSITIVE AML CELLS FROM TARGETED THERAPY

EHA Library, Elmira Vagapova, 325180

TAGRAXOFUSP IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM: LONG-TERM RESULTS FROM A PIVOTAL TRIAL

EHA Library, Naveen Pemmaraju, 325181

PROGNOSTIC FACTORS OF OVERALL AND RELAPSE-FREE SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION: MULTIVARIATE ANALYSES FROM THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE (ORAL-AZA )

EHA Library, Gail Roboz, 325182

TREATMENT FREE REMISSION (TFR) AFTER CEASING VENETOCLAX-BASED THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chong Chyn Chua, 325183

SECOND ALLOGENEIC STEM CELL TRANSPLANTATION FOR SECONDARY AML RELAPSING AFTER FIRST TRANSPLANTATION-A COMPARISON BETWEEN MYELOABLATIVE AND REDUCED INTENSITY CONDITIONING: FROM THE ALWP OF THE EBMT

EHA Library, Arnon Nagler, 325185

AGE-SPECIFIC CONDITIONAL RELATIVE SURVIVAL AMONG LONG-TERM ACUTE MYELOID LEUKEMIA (AML) SURVIVORS IN THE NETHERLANDS

EHA Library, Avinash Dinmohamed, 325188

A PHASE 1 STUDY OF GILTERITINIB IN COMBINATION WITH INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED AML: FINAL RESULTS UPDATE

EHA Library, Keith Pratz, 325191

FOLLOW-UP OF PATIENTS WITH FLT3-MUTATED RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA IN THE PHASE 3 ADMIRAL TRIAL

EHA Library, Mark Levis, 325192

CYTOPENIA MANAGEMENT IN THE PHASE 3 VIALE-C STUDY OF VENETOCLAX PLUS LOW-DOSE CYTARABINE FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Andrew Wei, 325193

OUTCOMES IN GILTERITINIB-TREATED FLT3-MUTATED R/R AML PATIENTS WHO UNDERWENT TRANSPLANTATION

EHA Library, Alexander Perl, 325195

RELATIONSHIP BETWEEN VENETOCLAX EXPOSURE AND POST-REMISSION CYTOPENIAS IN SUBJECTS WITH TREATMENT-NAÏVE ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX PLUS AZACITIDINE IN THE VIALE-A STUDY

EHA Library, Deanna Brackman, 325198

COMPARATIVE EFFICACY OF ORAL VERSUS INJECTABLE AZACITIDINE IN PATIENTS WITH AML IN FIRST REMISSION AFTER INTENSIVE CHEMOTHERAPY: AN INDIRECT TREATMENT COMPARISON (SUB-ANALYSIS UPDATE)

EHA Library, Clara Chen, 325200

ALLOGENIC STEM CELL TRANSPLANTATION ABROGATES NEGATIVE IMPACT ON OUTCOME OF AML PATIENTS WITH KMT2A PARTIAL TANDEM DUPLICATION

EHA Library, Gabriel Antherieu, 325211

RESULTS FROM DIAMOND-01 (CLI24-001) TRIAL: FIRST IN HUMAN STUDY OF SEL24/MEN1703, A DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Scott Solomon, 325215

A PHASE 3 STUDY OF ENASIDENIB (ENA) VERSUS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH LATE-STAGE MUTANT-IDH2 (MIDH2) RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

EHA Library, Courtney DiNardo, 325217

INDUCED SYSTEMIC T-CELL SPECIFIC RESPONSES TO MULTIPLE TUMOR-ASSOCIATED ANTIGENS AFTER ALLOGENIC LEUKEMIA-DERIVED DENDRITIC CELL VACCINE DCP-001 IN AML PATIENTS WITH PERSISTENT MRD

EHA Library, Hester J.T. Van Zeeburg, 325218

THE COMBINATION OF AXL INHIBITOR BEMCENTINIB AND LOW-DOSE CYTARABINE IS WELL TOLERATED AND EFFICACIOUS IN ELDERLY RELAPSED AML PATIENTS: UPDATE FROM THE ONGOING BGBC003 PHASE II TRIAL (NCT02488408)

EHA Library, Sonja Loges, 325223

UPDATED PHARMACODYNAMIC AND SURVIVAL OUTCOMES FROM THE AG221-AML-005 TRIAL OF ENASIDENIB (ENA) PLUS AZACITIDINE (AZA) IN PATIENTS WITH MUTANT IDH2 NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (ND-AML)

EHA Library, Courtney DiNardo, 325225

FLT3 INHIBITOR BASED INDUCTION AND ALLOGENEIC STEM CELL TRANSPLANT IN CR1 IMPROVE OUTCOMES IN PATIENTS WITH NEWLY DIAGNOSED AML VERY LOW FLT3 ALLELIC BURDEN

EHA Library, Musa Yilmaz, 325228

RE-STRATIFYING THE PROGNOSES OF ACUTE MYELOID LEUKEMIA PATIENTS WITH CEBPA DOUBLE MUTATIONS BY CSF3R MUTATIONS AND MINIMAL RESIDUAL DISEASE

EHA Library, SuJun Gao, 325229

SUPERIOR OUTCOMES FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION IN FIRST REMISSION FOR NPM1/FLT3-ITD MUTATED AML

EHA Library, Callum Wright, 325230